Clinical Trial Update: Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for the ADACEL booster vaccine in adolescents (Phase 1/Phase 2) with results posted in 2014, evaluating safety and immunogenicity against …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Pertussis, Tetanus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-02-21